EP3289876
EFNASAMBÖND TIL MEÐFERÐAR Á KRABBAMEINI
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
16.6.2009EP published:
20.7.2022EP application number:
17196904.1
EP translation filed:
27.10.2022Grant published:
15.12.2022EPO information:
European Patent Register
Max expiry date:
15.6.2029Expiry date:
15.6.2026Next due date:
30.6.2026
Title in English:
COMPOUNDS FOR TREATMENT OF CANCERLanguage of the patent:
English
Timeline
Today
16.6.2009EP application
20.7.2022EP Publication
27.10.2022Translation submitted
15.12.2022Registration published
15.6.2026Expires
Owner
Name:
University of Tennessee Research FoundationAddress:
211 Conference Center Building 600 Henley Street, Knoxville, TN 37996, US
Name:
Ohio State Innovation FoundationAddress:
1524 North High Street, Columbus, OH 43201, US
Inventor
Name:
MILLER, Duane, D.Address:
Collierville, TN 38017, US
Name:
LI, WeiAddress:
Germantown, TN 38139, US
Name:
WANG, ZhaoAddress:
North Potomac, MD 20878, US
Name:
LU, YanAddress:
Collierville, TN 38017, US
Name:
CHEN, JianjunAddress:
Guangzhou 510515, CN
Name:
DALTON, James, T.Address:
Tuscaloosa, AL 35406, US
Name:
LI, Chien-MingAddress:
Cupertino, CA 95014, US
Agent
Name:
COSMOVICI INTELLECTUAL PROPERTY SARLAddress:
11 Boulevard Sébastopol, FR
Priority
Number:
61875 PDate:
16.6.2008Country:
US
Classification
Categories:
A01N 43/64, A61K 31/41, C07D 233/02, C07D 233/22, C07D 233/54, C07D 263/06, C07D 263/14, C07D 277/04, C07D 401/04, C07D 401/06, C07D 413/04, C07D 413/06, C07D 417/06, A61K 31/4178, A61K 31/422, A61K 31/427, A61P 35/00
Annual fees
Number
Paid
Expires
Payer
Number: 15
Paid: 24.5.2023
Expires: 15.6.2024
Payer: Árnason Faktor ehf.
Number: 16
Paid: 7.5.2024
Expires: 15.6.2025
Payer: Árnason Faktor ehf.
Number: 17
Paid: 2.6.2025
Expires: 15.6.2026
Payer: Árnason Faktor ehf.